Related Articles
Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma
Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer
Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil
Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition
Dynamic quantitative detection of ABC transporter family promoter methylation by MS‑HRM for predicting MDR in pancreatic cancer